SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Remedium Lifecare planning to increase borrowing limit by issuance of debt securities

15 Jun 2023 Evaluate

Remedium Lifecare is planning to increase borrowing limit from Rs 50 crore to Rs 1000 crore by issuance of debt securities ie. Non -Convertible Debentures(NCD), Bank Term Loans etc. The company is also planning to consider and approve limit for investment by way of acquisition of Asset such as Plant &, Machinery, securities, etc upto Rs 1000 crore. The meeting of the Board of Directors of the Company is scheduled to be held on June 23, 2023 to consider the same.          

Remedium Lifecare is pharmaceutical company aligned across two business verticals viz. Products and Services.

Supha Pharmachem Share Price

0.28 -0.01 (-3.45%)
12-Jun-2026 16:01 View Price Chart
Peers
Company Name CMP
Redington 236.65
Amrapali Industries 35.09
Adani Enterprises 2920.25
Rashi Peripheral 558.50
PDS 306.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: